Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs – a systematic review and meta-analysis protocol

Key Points

• Leptospirosis patients face direct, indirect, and intangible costs that may affect their quality of life.
• Assessment includes evaluating the magnitude and aspects of these costs systematically.
• The analysis is based on a meta-analysis protocol registered under CRD 42024585056 for structured evaluation.
• Findings could inform healthcare policies and economic evaluations surrounding leptospirosis management.

Abstract